Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.96
+1.00 (7.72%)
May 20, 2026, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 624 employees as of December 31, 2025. The number of employees increased by 5 or 0.81% compared to the previous year.
Employees
624
Change (1Y)
5
Growth (1Y)
0.81%
Revenue / Employee
$473,409
Profits / Employee
-$79,615
Market Cap
2.23B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 624 | 5 | 0.81% |
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| GRAIL | 910 |
| CareDx | 765 |
ADPT News
- 8 days ago - Adaptive Biotechnologies price target lowered to $18 from $21 at Morgan Stanley - TheFly
- 14 days ago - Adaptive Biotechnologies price target lowered to $19 from $21 at JPMorgan - TheFly
- 14 days ago - Adaptive Biotechnologies price target raised to $21 from $19 at TD Cowen - TheFly
- 15 days ago - Adaptive Biotechnologies Earnings Call Transcript: Q1 2026 - Transcripts
- 15 days ago - Adaptive Biotechnologies Earnings release: Q1 2026 - Filings
- 15 days ago - Adaptive Biotechnologies Slides: Q1 2026 - Filings
- 15 days ago - Adaptive Biotechnologies Quarterly report: Q1 2026 - Filings
- 15 days ago - Adaptive Biotechnologies Reports First Quarter 2026 Financial Results - GlobeNewsWire